Browse Studies — Arctuva

Observational

A Multi-Center, Randomized, Controlled, Cross-Over Study to Evaluate the Effectiveness of Hypoxic Red Blood Cells Processed With the Hemanext ONE® System Versus Conventional Red Blood Cells in Patients With Transfusion Dependent Sickle Cell Anemia

The overall objective of this study is to evaluate the effectiveness and safety of transfusing hypoxic red blood cells manufactured with the Hemanext ONE syste…

Sickle Cell AnaemiaSickle Cell Anemia CrisisSickle Cell Anemia in Children+1 more

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Find your next paid study

Buprenorphine for the Management of Pain in Children With Sickle Cell Disease

A Multi-Center, Randomized, Controlled, Cross-Over Study to Evaluate the Effectiveness of Hypoxic Red Blood Cells Processed With the Hemanext ONE® System Versus Conventional Red Blood Cells in Patients With Transfusion Dependent Sickle Cell Anemia